Drug & Supplement Interactions

Schizonepeta + Repotrectinib

Brand name of Repotrectinib

  • Augtyro

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated November 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Moderate Interaction

Animal research suggests that schizonepetin, a monoterpene constituent of schizonepeta, induces cytochrome P450 (CYP) 3A4. This interaction is rated moderate.

This also applies to Augtyro, a brand name of repotrectinib.

Read the Full Interaction Report

Dr. Brian Staiger’s Quick Take

Schizonepeta may speed up the liver process that clears Augtyro, so less of your cancer medicine could stay active against the tumor, though this comes only from lab and animal data. Before adding this herb, please check with your oncologist or pharmacist.

Read his full note1-minute read
Moderate
Possible
D

Ask a Question About This Combination

Ask in your own words about taking Schizonepeta with Repotrectinib. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Schizonepeta and Repotrectinib Interaction

Here is the interaction we found between these two, with the evidence behind it.

Moderate Interaction

Schizonepeta With Cytochrome P450 3A4 (CYP3A4) Substrates

Why this applies to Repotrectinib

  1. The SupplementSchizonepeta
  2. Interacts With the CategoryCytochrome P450 3A4 (CYP3A4) Substrates
  3. Which IncludesRepotrectinib

We sort drugs into categories. Repotrectinib is in our Cytochrome P450 3A4 (CYP3A4) Substrates category, and Schizonepeta interacts with every drug in it, so this interaction applies to Repotrectinib.

Interaction Details Explained

Animal research suggests that schizonepetin, a monoterpene constituent of schizonepeta, induces cytochrome P450 (CYP) 3A4. Theoretically, schizonepeta might decrease the effects of CYP3A4 substrates.
Some substrates of CYP3A4 include lovastatin (Mevacor), ketoconazole (Nizoral), itraconazole (Sporanox), fexofenadine (Allegra), triazolam (Halcion), and numerous others.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on lab or animal research, not studies in people.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Schizonepeta + Repotrectinib Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the concern with pairing Schizonepeta and repotrectinib (Augtyro), your targeted cancer therapy for certain ROS1 and NTRK lung and solid tumors. Your body relies on a liver enzyme called CYP3A4 to process repotrectinib. Lab and animal studies hint that a compound in Schizonepeta may speed up that enzyme, which could clear the drug out of your system faster and leave less of it working against the cancer. In practice, that means it could weaken the very treatment you're counting on.

I want to be honest: this is only theory from test-tube and animal data, not proven in people. But with a cancer medicine, I don't like to gamble. Please loop in your oncologist or pharmacist before adding this herb.

Still have a question about this interaction?

Contact Dr. Brian directly

References 1 source behind this record

  1. Bao B, Geng T, Cao Y, et al. Effects of schizonepetin on activity of mRNA expression of cytochrome P450 enzymes in rats. Int J Mol Sci. 2012;13(12):17006-18.
Know someone taking this combination? Share

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Schizonepeta Also Interacts With Other Medications

Besides Repotrectinib, Schizonepeta has 798 moderate known drug interactions in our database. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Schizonepeta

Covers the 2,830 medications we’ve checked against Schizonepeta. Pick one to open its full report.

Everything Else You Take

See Every Supplement That Interacts With Repotrectinib

Take other supplements too? 190 supplements have a documented interaction with Repotrectinib, each explained on its page.

By severity: 6 major, 146 moderate and 38 minor.

The Most Serious There Right Now:

Open the Repotrectinib interaction pageEvery supplement checked against Repotrectinib, ranked by severity
One More Smart Check

Taking Schizonepeta as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Schizonepeta. We have broken down 285 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against Repotrectinib:

Get to Know Each One

About Schizonepeta and Repotrectinib

Supplement

About Schizonepeta

Schizonepeta is a mint-family herb long used in traditional Chinese medicine, usually as part of combination formulas for colds, fevers, and itchy skin conditions. Modern human evidence is very limited, so its benefits are not well proven. Talk to a pharmacist or doctor before using it, especially if you are pregnant, breastfeeding, or taking other medicines.

Full Schizonepeta guide: uses, dosage, safety and every interaction
Medication

About Repotrectinib

Brand name: Augtyro

Repotrectinib, sold as Augtyro capsules, treats certain cancers driven by specific gene changes. Your tumor must test positive for the gene change.

Repotrectinib: uses, dosage and side effects Repotrectinib: interactions with other drugs Taking more than these two? Check Schizonepeta and Repotrectinib with everything else you take Repotrectinib NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Similar Pairs

More Pairs Like Schizonepeta and Repotrectinib

Other drugs in the category this interaction applies to, and other supplements people check with Repotrectinib.

Moderate

Also in Our Cytochrome P450 3A4 (CYP3A4) Substrates Category

Schizonepeta interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

384 more in this category are on the Schizonepeta interactions list.

Other Supplements With Repotrectinib

The most serious documented interactions with Repotrectinib first, then supplements with none on record, the most looked-up leading.

Show all 25 supplementsShow fewer
Keep Checking

Other Drugs & Schizonepeta

Browse every other medication we’ve checked against Schizonepeta — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
798Moderate
0Minor
2,031No known interaction
Moderate

Moderate: 798 interactions

Showing 60 of 798 moderate interactions — see all 798 on the Schizonepeta page.

No Interaction 2,031 drugs checked — show the list

We also checked Schizonepeta against these medications and found no known interaction in our sources. Open any page to confirm.

Showing 60 of the 2,031 medications checked with no known interaction, the most looked-up first — see the full Schizonepeta list.

How Much People Look This Up

Where Schizonepeta and Repotrectinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Schizonepeta
Top half

#455 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Repotrectinib
Steady interest

#1,921 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Schizonepeta and Repotrectinib Together: Common Questions

Can you take Schizonepeta with Repotrectinib?
There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Read the full details on this page and confirm with your pharmacist before combining them.
Can you take Schizonepeta with Augtyro?
Augtyro is a brand name of repotrectinib, so the answer is the same as for repotrectinib. There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Everything on this page applies to Augtyro too.
How serious is the Schizonepeta and Repotrectinib interaction?
We rate it Moderate. This combination may require monitoring, a dose adjustment, or separating the times you take each one. Consult your pharmacist before using them together.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Sources

Sources & How We Checked

Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.

Content is reviewed by the HelloPharmacist Editorial Team, the pharmacists on our staff and those we contract. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep Exploring
Rating Key

What Our Interaction Ratings Mean

Every interaction on this page is rated three ways: how serious it is, how likely it is to happen, and how strong the research behind it is.

See what each rating means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Likelihood: How Likely Is It to Happen?

How strong the proof is that the interaction really happens in people. More filled steps, stronger proof.

  • LikelyShown in well-controlled studies in people.
  • ProbableShown in small studies in people, or in animal studies backed by case reports.
  • PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
  • UnlikelySeen in lab or animal research, but shown not to happen in people.

Evidence: How Strong Is the Research?

The quality of the studies behind the rating, graded from A, the strongest, to D.

  • Grade AStrong: well-run randomized trials in people, or a review that pooled several of them.
  • Grade BFair: smaller or less rigorous trials in people, or studies that followed or compared groups of people.
  • Grade CLimited: the agreement or opinion of experts, not studies.
  • Grade DWeak: reports of single cases, lab or animal research, or what is expected from how the two work.

Still Have a Question About Schizonepeta and Repotrectinib?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.